Conor Woolfson

Conor Woolfson is a seasoned Chief Financial Officer with a robust background in engineering and finance. They began their career as a Manufacturing Engineer at Ash Technologies, later gaining experience as an Audit Senior at Mazars and a Financial Accountant at Enstar Group. Over the years, Conor has held various significant financial roles, including Finance Director at VaxEquity Ltd and Group Financial Controller at IXICO. Currently, they serve as CFO for multiple companies, including Concr, Mevox Ltd, Tay Therapeutics Ltd, and Hawkhill Therapeutics Ltd, where they leverage machine learning and innovative therapeutics in their financial strategies. Conor's education includes an ACA from Chartered Accountants Ireland and a Bachelor of Engineering from University College Dublin.